Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Roberts

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Bioactive Materials|October 13, 2025
Spermidine reduces peri-implant inflammation and fibrosis to nurture osseointegrationQiming Liu, Qianqian Wu, Tingting Cao, et al.
Nature|July 13, 2010
Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial developmentHank H Qi, Madathia Sarkissian, Gang-Qing Hu, et al.
Cancer Discovery|July 12, 2013
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)Manav Korpal, Joshua M Korn, Xueliang Gao, et al.
Journal for Immunotherapy of Cancer|July 31, 2021
Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancerGi-Hoon Nam, Minsu Kwon, Hanul Jung, et al.
Journal for Immunotherapy of Cancer|January 7, 2023
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancerLiya Ding, Qiwei Wang, Antons Martincuks, et al.
Nature|June 14, 2017
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survivalHaizhen Wang, Brandon N Nicolay, Joel M Chick, et al.
Cell Reports|December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian CancerLiya Ding, Hye-Jung Kim, Qiwei Wang, et al.
Molecular Cancer Research : MCR|February 2, 2022
Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate CancerXueliang Gao, Yubao Wang, Caroline F Ribeiro, et al.
Nature Communications|May 31, 2022
STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancerQiwei Wang, Johann S Bergholz, Liya Ding, et al.
Nature|August 17, 2017
CDK4/6 inhibition triggers anti-tumour immunityShom Goel, Molly J DeCristo, April C Watt, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Bioactive Materials|October 13, 2025
Spermidine reduces peri-implant inflammation and fibrosis to nurture osseointegrationQiming Liu, Qianqian Wu, Tingting Cao, et al.
Nature|July 13, 2010
Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial developmentHank H Qi, Madathia Sarkissian, Gang-Qing Hu, et al.
Cancer Discovery|July 12, 2013
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)Manav Korpal, Joshua M Korn, Xueliang Gao, et al.
Journal for Immunotherapy of Cancer|July 31, 2021
Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancerGi-Hoon Nam, Minsu Kwon, Hanul Jung, et al.
Journal for Immunotherapy of Cancer|January 7, 2023
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancerLiya Ding, Qiwei Wang, Antons Martincuks, et al.
Nature|June 14, 2017
The metabolic function of cyclin D3-CDK6 kinase in cancer cell survivalHaizhen Wang, Brandon N Nicolay, Joel M Chick, et al.
Cell Reports|December 13, 2018
PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian CancerLiya Ding, Hye-Jung Kim, Qiwei Wang, et al.
Molecular Cancer Research : MCR|February 2, 2022
Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant Prostate CancerXueliang Gao, Yubao Wang, Caroline F Ribeiro, et al.
Nature Communications|May 31, 2022
STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancerQiwei Wang, Johann S Bergholz, Liya Ding, et al.
Nature|August 17, 2017
CDK4/6 inhibition triggers anti-tumour immunityShom Goel, Molly J DeCristo, April C Watt, et al.
Pageof 13